Drug & Supplement Interactions

Feverfew + Erdafitinib

Brand name of Erdafitinib

  • Balversa

Medically reviewed by

Also reviewed by the HelloPharmacist Editorial Team

Updated November 2026Details about this page

AI is used only to summarize verified clinical information, never the open internet. Our AI policy

The Bottom Line Moderate Interaction

Theoretically, feverfew might increase levels of drugs metabolized by CYP2C9. Of the 2 interaction records for this pair, the most serious is rated moderate.

This also applies to Balversa, a brand name of erdafitinib.

Read the Full Interaction Report

Dr. Brian Staiger’s Quick Take

Feverfew might slow a liver enzyme that clears Balversa, possibly letting it build up and raise side effects like mouth sores and dry eyes. This idea comes only from lab work, so talk with your oncology team or pharmacist first.

Read his full note1-minute read
Moderate
Possible
2
D

Ask a Question About This Combination

Ask in your own words about taking Feverfew with Erdafitinib. The answer comes from this page’s own records.

Try:

AI answers from this page’s interaction records and our own drug and supplement information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI

Interaction Report

Feverfew and Erdafitinib Interaction

2 interaction records apply to these two. Each one is explained separately below.

Why Are There 2 Interaction Records?

We file Feverfew’s interactions under single medicines and under categories of medicines that share an effect. Erdafitinib is named in, or belongs to, 2 of them, so 2 records apply. They can describe the same effect, so they are not 2 separate risks. We’ve listed each one below; the most serious of them (Moderate) sets the overall rating.

Moderate Interaction 1 of 2

Feverfew With Cytochrome P450 2C9 (CYP2C9) Substrates

Why this applies to Erdafitinib

  1. The SupplementFeverfew
  2. Interacts With the CategoryCytochrome P450 2C9 (CYP2C9) Substrates
  3. Which IncludesErdafitinib

We sort drugs into categories. Erdafitinib is in our Cytochrome P450 2C9 (CYP2C9) Substrates category, and Feverfew interacts with every drug in it, so this interaction applies to Erdafitinib.

Interaction Details Explained

Theoretically, feverfew might increase levels of drugs metabolized by CYP2C9.
Laboratory research shows that feverfew might inhibit CYP2C9. So far, this interaction has not been reported in humans.
Severity
ModerateUse caution: it may call for monitoring, timing changes or a dose change.
Likelihood
PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
Evidence
Grade DBased on lab or animal research, not studies in people.

What every rating means

Dr. Brian Staiger, PharmD, BCPS
Explaining the Feverfew + Cytochrome P450 2C9 (CYP2C9) Substrates Interaction in Plain Words By Dr. Brian Staiger, PharmD, clinical pharmacist

Here's the gist with feverfew and erdafitinib (Balversa). Erdafitinib is partly cleared by a liver enzyme called CYP2C9. Lab studies hint that feverfew may slow that same enzyme down. If that happened in real life, erdafitinib could build up a bit and push its effects (and side effects) higher. With this drug that might mean more mouth sores, dry mouth and dry eyes, nail changes, diarrhea, or the eye and high-phosphate issues it's already watched for.

The honest part: this is theoretical, based only on lab work, and has not been seen in people. Erdafitinib is a serious cancer medicine, so don't add feverfew on your own. Run it by your oncology team or pharmacist first.

Still have a question about this interaction?

Contact Dr. Brian directly

References 1 source behind this record

  1. Unger M, Frank A. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun Mass Spectrom 2004;1 PubMed
Moderate Interaction 2 of 2

Feverfew With Cytochrome P450 3A4 (CYP3A4) Substrates

Erdafitinib is also in our Cytochrome P450 3A4 (CYP3A4) Substrates category.

Interaction Details Explained

Theoretically, feverfew might increase levels of drugs metabolized by CYP3A4.
Laboratory research shows that feverfew might inhibit CYP3A4. So far, this interaction has not been reported in humans.
Severity
ModerateUse caution: it may call for monitoring, timing changes or a dose change.
Likelihood
PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
Evidence
Grade DBased on lab or animal research, not studies in people.

What every rating means

Dr. Brian Staiger, PharmD, BCPS
Explaining the Feverfew + Cytochrome P450 3A4 (CYP3A4) Substrates Interaction in Plain Words By Dr. Brian Staiger, PharmD, clinical pharmacist

Here's the simple version: your bladder cancer medicine, erdafitinib (Balversa), is cleared from your body in part by a liver enzyme called CYP3A4. Lab research hints that feverfew may slow that same enzyme down. If that happened in people, erdafitinib could build up a bit higher than expected, which might mean more of its known side effects, things like dry mouth and eyes, mouth sores, changes in your nails or skin, diarrhea, and especially vision or eye problems.

The important caveat: this is only test-tube and animal data, and it has never actually been reported in humans. So I wouldn't panic. Still, because erdafitinib is a serious cancer drug with careful monitoring, please run any feverfew use past your oncologist or pharmacist first.

Still have a question about this interaction?

Contact Dr. Brian directly

References 2 sources behind this record

  1. Unger M, Frank A. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun Mass Spectrom 2004;1 PubMed
  2. Sil'vestrov VP, Kinitin AV, and Chesnokova, IV. [Immunological and metabolic disorders and the means for their correction in patients with chronic bronchitis]. Ter.Arkh. 1991;63:7-11.
Know someone taking this combination? Share

Your Whole Routine

Your Other Medicines and Supplements

Keep It in Perspective

Feverfew Also Interacts With Other Medications

Besides Erdafitinib, Feverfew has 930 moderate known drug interactions in our database. If you take anything else, check it against the full list below.

Taking Anything Else?

Check Another of Your Medications Against Feverfew

Covers the 2,830 medications we’ve checked against Feverfew. Pick one to open its full report.

Everything Else You Take

See Every Supplement That Interacts With Erdafitinib

Take other supplements too? 174 supplements have a documented interaction with Erdafitinib, each explained on its page.

By severity: 4 major, 130 moderate and 40 minor.

The Most Serious There Right Now:

Open the Erdafitinib interaction pageEvery supplement checked against Erdafitinib, ranked by severity
One More Smart Check

Taking Feverfew as Part of a Dietary Supplement Product? Check It for Interactions

A product can hold more than Feverfew. We have broken down 520 supplement products that contain it, ingredient by ingredient. Find yours and we’ll check every ingredient against Erdafitinib:

Get to Know Each One

About Feverfew and Erdafitinib

Supplement

About Feverfew

Feverfew

Feverfew is a daisy-family herb best known for migraine prevention, where some studies suggest it may modestly lower how often migraines occur, though the evidence is mixed. It is generally well tolerated for short-term use in most adults but should be avoided during pregnancy and breastfeeding and by people allergic to ragweed and related plants. Talk to your pharmacist or doctor before starting it.

Full Feverfew guide: uses, dosage, safety and every interaction
Medication

About Erdafitinib

Brand name: Balversa

Erdafitinib, sold as Balversa, treats adults with locally advanced or metastatic urothelial carcinoma (cancer of the bladder and urinary tract that has spread or can't be removed). The tumor must have susceptible FGFR3 genetic alterations, and the cancer must have progressed on or after at least one earlier systemic therapy.

Erdafitinib: uses, dosage and side effects Erdafitinib: interactions with other drugs Taking more than these two? Check Feverfew and Erdafitinib with everything else you take Erdafitinib NDC codes and packages

More to Explore

More Pairs and Interactions to Check

Similar Pairs

More Pairs Like Feverfew and Erdafitinib

Other drugs in the category this interaction applies to, and other supplements people check with Erdafitinib.

Moderate

Also in Our Cytochrome P450 2C9 (CYP2C9) Substrates Category

Feverfew interacts with every drug in this category, so each of these has the same interaction. The category is about a shared effect, not about being the same kind of medicine.

Show all 16 drugs in this categoryShow fewer

95 more in this category are on the Feverfew interactions list.

Moderate

Also in Our Cytochrome P450 3A4 (CYP3A4) Substrates Category

Feverfew interacts with every drug in this category, so each of these has the same interaction. The category is about a shared effect, not about being the same kind of medicine.

Show all 16 drugs in this categoryShow fewer

383 more in this category are on the Feverfew interactions list.

Other Supplements With Erdafitinib

The most serious documented interactions with Erdafitinib first, then supplements with none on record, the most looked-up leading.

Show all 26 supplementsShow fewer
Keep Checking

Other Drugs & Feverfew

Browse every other medication we’ve checked against Feverfew — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
930Moderate
0Minor
1,899No known interaction
Moderate

Moderate: 930 interactions

Showing 60 of 930 moderate interactions — see all 930 on the Feverfew page.

No Interaction 1,899 drugs checked — show the list
How Much People Look This Up

Where Feverfew and Erdafitinib Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Feverfew
Top 10%

#119 of 1,458 supplements looked up here in the last 7 days

29 days ago today
Medication Erdafitinib
Steady interest

#1,613 of 2,830 medications looked up here in the last 7 days

29 days ago today

A rank of lookups on this site, not of how often either one is used. It counts every visit, automated ones included, and identifies no one.

Questions and Sources

Common Questions and Where This Comes From

Pharmacist Counseling Corner

Taking Feverfew and Erdafitinib Together: Common Questions

Can you take Feverfew with Erdafitinib?
There is a moderate interaction, so it may be acceptable with monitoring or timing changes. Read the full details on this page and confirm with your pharmacist before combining them.
Can you take Feverfew with Balversa?
Balversa is a brand name of erdafitinib, so the answer is the same as for erdafitinib. There is a moderate interaction, so it may be acceptable with monitoring or timing changes. Everything on this page applies to Balversa too.
Why are there 2 interaction records for Feverfew and Erdafitinib?
We file interactions under single medicines and under categories of medicines that share an effect. Erdafitinib is named in, or belongs to, 2 of the categories we list for Feverfew, so 2 records apply. They can describe the same effect, so they are not 2 separate risks. We list every one so nothing is missed, and the most serious one sets the overall rating.
How serious is the Feverfew and Erdafitinib interaction?
We rate it Moderate. This combination may require monitoring, a dose adjustment, or separating the times you take each one. Consult your pharmacist before using them together.

Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy

Sources

Sources & How We Checked

Interaction details are evidence-graded and sourced from the Natural Medicines database. The medication overview comes from MedlinePlus.

Content is reviewed by the HelloPharmacist Editorial Team, the pharmacists on our staff and those we contract. See our data sources and editorial standards for how this information is built and checked.

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep Exploring
Rating Key

What Our Interaction Ratings Mean

Every interaction on this page is rated three ways: how serious it is, how likely it is to happen, and how strong the research behind it is.

See what each rating means

Severity: How Serious Is It?

How clinically significant the interaction is: how much it could affect your health or your treatment.

  • MajorClinically significant. Best to avoid the combination, or use only under close professional supervision.
  • ModerateBe cautious. The combination may call for monitoring, timing changes, or a dose adjustment.
  • MinorLimited clinical concern, but still worth being aware of and mentioning to your pharmacist.
  • No Known InteractionNo documented interaction in our sources.

Likelihood: How Likely Is It to Happen?

How strong the proof is that the interaction really happens in people. More filled steps, stronger proof.

  • LikelyShown in well-controlled studies in people.
  • ProbableShown in small studies in people, or in animal studies backed by case reports.
  • PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
  • UnlikelySeen in lab or animal research, but shown not to happen in people.

Evidence: How Strong Is the Research?

The quality of the studies behind the rating, graded from A, the strongest, to D.

  • Grade AStrong: well-run randomized trials in people, or a review that pooled several of them.
  • Grade BFair: smaller or less rigorous trials in people, or studies that followed or compared groups of people.
  • Grade CLimited: the agreement or opinion of experts, not studies.
  • Grade DWeak: reports of single cases, lab or animal research, or what is expected from how the two work.

Still Have a Question About Feverfew and Erdafitinib?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.